Mahavir Agarwal
Centre for Addiction and Mental Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mahavir Agarwal as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:31 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07109245 · Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?Centre for Addiction and Mental Health · recruiting · Brain Insulin Sensitivity, Healthy Controls, Cognition · principal investigator
- N/ANCT06251635 · Effects of Antipsychotics on Brain Insulin Action in FemalesCentre for Addiction and Mental Health · active not recruiting · Insulin Resistance, Menstrual Cycle, Type 2 Diabetes · principal investigator
- N/ANCT05571878 · Is Brain Insulin Resistance a Feature of the Biology of Depression in AdolescentsCentre for Addiction and Mental Health · completed · Major Depressive Disorder, Depression · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:31 UTC. The ranking covers the 200 most relevant of 64 PubMed records, and a shared surname and initials can bring in a namesake. All 64 on PubMed
- A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).Am J Transplant · 2010769 citationsRCR 21.0
- 471 citationsRCR 12.6
- Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.Am J Transplant · 2012250 citationsRCR 7.8
- Long-term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial.Br J Haematol · 1992165 citationsRCR 6.8
- Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients.Am J Transplant · 2011165 citationsRCR 5.0
- Five-year safety and efficacy of belatacept in renal transplantation.J Am Soc Nephrol · 2010145 citationsRCR 3.8
- 128 citationsRCR 5.6
- Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study.Am J Transplant · 2014116 citationsRCR 4.2
- Safety and efficacy of ultrasonography as an adjunct to fluoroscopy for renal access in percutaneous nephrolithotomy (PCNL).BJU Int · 201198 citationsRCR 5.3
- Intraoperative glove perforation--single versus double gloving in protection against skin contamination.Postgrad Med J · 200190 citationsRCR 4.0